FDA inspection
Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd: FDA inspection ending Oct 24, 2025
FDA inspection 1293216 · No Action Indicated (NAI) · Jinhua
Key facts
| Inspection ID | 1293216 |
|---|---|
| Firm | Zhejiang Apeloa Tospo Pharmaceuticals Co., Ltd |
| FEI number | 3008259952 |
| Address | 519 Jiang Shanbeicun, Hengdianzhen Dongyang |
| City | Jinhua |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | Oct 24, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data